Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendra Sweet

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Leukemia & Lymphoma|August 20, 2020
Updated safety of midostaurin plus chemotherapy in newly diagnosed <i>FLT3</i> mutation-positive acute myeloid leukemia: the RADIUS-X expanded access programGail J Roboz, Stephen A Strickland, Mark R Litzow, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2020
Decoding Bone Marrow Fibrosis in Myelodysplastic SyndromesMegan Melody, Najla Al Ali, Ling Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid LeukemiaDasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2020
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase KaryotypeZaker I Schwabkey, Najla Al Ali, Onyee Chan, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 15, 2021
Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia: A Pilot StudyKelly A Hyland, Ashley M Nelson, Sarah L Eisel, et al.
Blood Advances|July 30, 2020
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplantSeongseok Yun, Onyee Chan, Daniel Kerr, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid LeukemiaAkriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|June 24, 2022
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromesVirginia O Volpe, Najla Al Ali, Onyee Chan, et al.
Leukemia & Lymphoma|August 20, 2020
Updated safety of midostaurin plus chemotherapy in newly diagnosed <i>FLT3</i> mutation-positive acute myeloid leukemia: the RADIUS-X expanded access programGail J Roboz, Stephen A Strickland, Mark R Litzow, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2020
Decoding Bone Marrow Fibrosis in Myelodysplastic SyndromesMegan Melody, Najla Al Ali, Ling Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2022
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid LeukemiaDasom Lee, Akriti G Jain, Yehuda Deutsch, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2025
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease ProgressionLuis E Aguirre, Somedeb Ball, Akriti Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2020
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase KaryotypeZaker I Schwabkey, Najla Al Ali, Onyee Chan, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 15, 2021
Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia: A Pilot StudyKelly A Hyland, Ashley M Nelson, Sarah L Eisel, et al.
Blood Advances|July 30, 2020
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplantSeongseok Yun, Onyee Chan, Daniel Kerr, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid LeukemiaAkriti G Jain, Somedeb Ball, Luis E Aguirre, et al.
Pageof 9